Searched for
NDDS
IPO-bound Tata Play slips into net loss of Rs 105 croreAs per the financial data accessed by Tofler, the direct-to-home (DTH) company's revenue from operations for the fiscal year dropped 5.1% t...- National narco detection K9 pool to be raised with 70 dogs in first goThe pool of narcotics detection dogs (NDDs) will be raised in collaboration with the K9 (canine) cell of the Union home ministry, Narcotics...
- Sun Pharma may file new drug application with USFDA: Dilip ShanghviSun Pharma may file application for a new drug with the US Food and Drug Administration in next two to three years,Dilip Shanghvi said.
- Cadila buys JV partner's 50 pc stake in Zydus BSV PharmaZydus BSV Pharma, founded in 2005, is a joint venture (JV) company of Cadila Healthcare and biotech firm Bharat Serums and Vaccines (BSV).
- Wockhardt gets USFDA approval for anti-ulcer drugDrug firm Wockhardt today said it has received approval from American health regulator to market Lansoprazole, a drug used in treatment of ...
- Wockhardt gets USFDA nod for generic UroxatralWockhardt today said it has received approval from the American health regulator USFDA to market Alfuzosin hydrochloride tablets.
- Venus Remedies launches pain killer injection in domestic mktDrug firm Venus Remedies today said it has launched its 'Achnil' injection, a pain killer, in the country's pharmaceutical market.
- Lincoln Pharma gets patent approval for nasal spray treatmentLincoln Pharmaceuticals on Monday said it has received patent approval for a nasal spray, which would help prevent vomiting and nausea.
- Elder Pharma to strengthen position in womencare, neutraceutical segmentsThe company aims to increase its reach and market share in the two segments, both through in-licensing products and its own products.
- Elder enters nutraceutical segement, develops first drugThe latest to join the nutraceutical business is the Mumbai-based Rs 600-crore company Elder Pharmaceuticals, which has just developed its ...
- Zydus Healthcare launches NDDS product NudoxaZydus Cadila has introduced an NDDS product for treatment of various types of cancer, which is stable and long lasting with reduced toxicit...
- Pharma companies demerging NCE, NDDS operationsPharma majors are de-merging their NCE operations into separate cos to scale-up their activities and achieve better focus. Drug cos in pric...
- Ranbaxy forays into authorised generics in USPharmaceutical major Ranbaxy Laboratories on Monday said it has commercialised its first authorised generic product, Isoptin SR - an anti h...
- Panacea Biotec to enter oncology segmentBiotech firm Panacea Biotec on Thursday said it is planning to foray into oncology segment.
- Alembic signs licensing agreement with UCBAlembic today said it has signed $11 million licensing agreement with Belgium-based UCB for anti-epileptic drug Keppra.
- Indoco set to board NDDS platformMid-sized pharma company Indoco Remedies plans to start manufacturing novel drugs under the novel drug delivery system (NDDS) platform.
- Ranbaxy unveils two new drugsRanbaxy Labs on Monday announced the launch of two Novel Drug Delivery System (NDDS) products in the Urology Segment. Niftran 100mg Capsule...
- NPIL expects Rs 1,000 cr revenueAs the costs of medicines are high abroad, the MNCs need Indian companies to manufacture their products.
- Lincoln's patent on 'Vivian Roll On' acceptedPharmaceutical company, Lincoln Pharmaceuticals Ltd on Thursday said its application for the patent of Vivian Roll On, the composition comp...
- Wockhardt gets nod for new drugWockhardt Ltd has received tentative approval from the USFDA for anti-epileptic drug, Divalproex Sodium delayed-release tablets.
Load More
